These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 12387624
1. Investigation of the role of lipoxygenase in bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung. Bedard LL, Smith GB, Reid KR, Petsikas D, Massey TE. Chem Res Toxicol; 2002 Oct; 15(10):1267-73. PubMed ID: 12387624 [Abstract] [Full Text] [Related]
8. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes. Patten CJ, Smith TJ, Murphy SE, Wang MH, Lee J, Tynes RE, Koch P, Yang CS. Arch Biochem Biophys; 1996 Sep 01; 333(1):127-38. PubMed ID: 8806763 [Abstract] [Full Text] [Related]
9. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate. Smith TJ, Guo Z, Guengerich FP, Yang CS. Carcinogenesis; 1996 Apr 01; 17(4):809-13. PubMed ID: 8625495 [Abstract] [Full Text] [Related]
10. Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in lung tissue from mouse, rat, hamster, and man. Richter E, Engl J, Friesenegger S, Tricker AR. Chem Res Toxicol; 2009 Jun 01; 22(6):1008-17. PubMed ID: 19408892 [Abstract] [Full Text] [Related]
11. Metabolic activation of the tobacco carcinogen 4-(methylnitrosamino)-(3-pyridyl)-1-butanone by cytochrome P450 2A13 in human fetal nasal microsomes. Wong HL, Zhang X, Zhang QY, Gu J, Ding X, Hecht SS, Murphy SE. Chem Res Toxicol; 2005 Jun 01; 18(6):913-8. PubMed ID: 15962925 [Abstract] [Full Text] [Related]
13. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human kidney epithelial cells transfected with rat CYP2B1 cDNA. Lacroix D, Desrochers M, Castonguay A, Anderson A. Carcinogenesis; 1993 Aug 01; 14(8):1639-42. PubMed ID: 8353848 [Abstract] [Full Text] [Related]
15. Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13. Jalas JR, Ding X, Murphy SE. Drug Metab Dispos; 2003 Oct 01; 31(10):1199-202. PubMed ID: 12975327 [Abstract] [Full Text] [Related]
16. Mechanisms of inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation in mouse by dietary phenethyl isothiocyanate. Smith TJ, Guo Z, Li C, Ning SM, Thomas PE, Yang CS. Cancer Res; 1993 Jul 15; 53(14):3276-82. PubMed ID: 8324738 [Abstract] [Full Text] [Related]
17. Carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in cytosol of mouse liver and lung. Atalla A, Maser E. Toxicology; 1999 Nov 29; 139(1-2):155-66. PubMed ID: 10614696 [Abstract] [Full Text] [Related]
20. Effects of phenobarbital and 3-methylcholanthrene induction on the formation of three glucuronide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, NNK. Murphy SE, Nunes MG, Hatala MA. Chem Biol Interact; 1997 Mar 14; 103(3):153-66. PubMed ID: 9134006 [Abstract] [Full Text] [Related] Page: [Next] [New Search]